Hoth Therapeutics Inc Cash Flow-to-Debt Ratio
Hoth Therapeutics Inc cash flow-to-debt ratio. Hoth Therapeutics Inc (HOTH) has a Cash Flow-to-Debt Ratio of -2.15x as of June 2026, meaning its operating cash flow of $-2.97 Million could theoretically repay -2% of its total liabilities ($1.38 Million) in one year. See HOTH financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hoth Therapeutics Inc (2017–2025)
Cash flow-to-debt ratio of Hoth Therapeutics Inc from 2017 to 2025. Historical debt coverage capacity for Hoth Therapeutics Inc across 9 annual periods. Also explore Hoth Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Hoth Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
Hoth Therapeutics Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Hoth Therapeutics Inc. For the full cash flow conversion analysis, see HOTH cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.75x | $-9.80 Million | $1.45 Million | ▲ +19.4% |
| 2024 | -8.37x | $-6.98 Million | $833.91K | ▲ +30.2% |
| 2023 | -11.98x | $-8.45 Million | $704.98K | ▼ -111.1% |
| 2022 | -5.68x | $-9.30 Million | $1.64 Million | ▲ +48.2% |
| 2021 | -10.96x | $-12.09 Million | $1.10 Million | ▼ -6.7% |
| 2020 | -10.27x | $-6.13 Million | $597.15K | ▲ +8.6% |
| 2019 | -11.24x | $-4.95 Million | $440.12K | ▼ -86.5% |
| 2018 | -6.03x | $-2.10 Million | $348.95K | ▲ +35.9% |
| 2017 | -9.41x | $-465.24K | $49.47K | — |